SCHEDULE: Bank of America Discloses 6.5% Stake in Rezolute
Beneficial Ownership Disclosure
Bank of America Corporation has reported a 6.5% beneficial ownership stake in Rezolute, Inc.'s common stock as of December 31, 2025.
Summary
- Bank of America Corporation /DE/ (BAC) has filed a Schedule 13G, reporting beneficial ownership in Rezolute, Inc. (RZLT) common stock.
- BAC beneficially owns 6,064,486 shares of Rezolute, Inc. common stock.
- This represents 6.5% of Rezolute, Inc.'s outstanding common stock.
- The ownership calculation is based on 92,727,532 outstanding shares of Rezolute, Inc. as disclosed in its Form 10-Q on November 6, 2025, with share totals as of November 4, 2025.
- BAC holds shared voting power and shared dispositive power over all 6,064,486 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Rezolute, Inc.
- The filing is made on behalf of Bank of America Corporation and its wholly-owned subsidiaries: BofA Securities, Inc., Bank of America N.A., and Merrill Lynch International.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a routine disclosure of a significant institutional stake. While not directly indicative of Rezolute's operational performance, a major bank holding a 6.5% position can be seen as a minor positive signal of institutional confidence.
Positives
- Bank of America's significant 6.5% stake in Rezolute, Inc. could be interpreted as a vote of confidence from a major financial institution.
- The acquisition of shares in the ordinary course of business suggests a routine investment rather than a hostile or activist intent.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Rezolute, Inc.'s future performance or Bank of America's future investment plans.
Industry Context
StockSavvy.ai notes that institutional filings like Schedule 13G provide transparency into significant ownership stakes, which can influence market perception. A major financial institution like Bank of America taking a 6.5% position in a company like Rezolute, Inc. (likely a biotech or pharmaceutical firm given its name and common stock structure) is a routine disclosure but can signal institutional interest. This type of filing is common across various industries as large investors cross ownership thresholds.
Comparison to Industry Standards
- This filing is a standard regulatory disclosure of beneficial ownership. There are no specific results to compare against global benchmarks or comparable companies.
- The 6.5% stake is a significant institutional holding, typical for large asset managers or financial institutions in publicly traded companies.
Stakeholder Impact
- Shareholders: Existing shareholders may view Bank of America's stake as a positive signal of institutional interest and potential stability.
- Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this ownership disclosure.
Key Dates
| Date | Description |
|---|---|
| 2025-11-04 | Date as of which Rezolute, Inc. reported 92,727,532 outstanding shares in its Form 10-Q. |
| 2025-11-06 | Date Rezolute, Inc. filed its Form 10-Q disclosing outstanding shares. |
| 2025-12-31 | Date of event which required the filing of this Schedule 13G. |
| 2026-02-11 | Date the Schedule 13G was signed by Bank of America Corp /DE/. |
Recommendation
holdThis Schedule 13G filing indicates a significant, passive institutional investment by Bank of America in Rezolute, Inc. While the 6.5% stake suggests institutional confidence, the filing itself provides no new operational or financial performance data for Rezolute, Inc. to warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and await further operational updates from Rezolute, Inc. to assess its fundamental value.
Keywords
Rezolute Inc, RZLT, Bank of America, BAC, Schedule 13G, beneficial ownership, common stock, institutional ownership, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.